%0 Journal Article
%T Cancer mortality trends in the Umbria region of Italy 1978¨C2004: a joinpoint regression analysis
%A Fabrizio Stracci
%A Antonio Canosa
%A Liliana Minelli
%A Anna Maria Petrinelli
%A Tiziana Cassetti
%A Carlo Romagnoli
%A Francesco La Rosa
%J BMC Cancer
%D 2007
%I BioMed Central
%R 10.1186/1471-2407-7-10
%X Mortality data for the periods 1978¨C1993 and 1994¨C2004 were supplied by the National Institute of Statistics (ISTAT) and the Regional Causes of Death Registry (ReNCaM) respectively. Sex and site-specific mortality time trends were analysed by the "joinpoint regression" method.For all sites combined, in both sexes, the standardised rate was first increasing before the end of the eighties and decreasing thereafter. Gastric cancer mortality showed a different trend by gender; that is the rate constantly decreased over the period among females while, for males, it was first increasing up to 1985 and decreasing thereafter. Liver cancer trend showed a pattern similar to gastric cancer. Large bowel cancer showed a gender specific trend, that is it was increasing among males and stable among females. Also lung cancer mortality varied by gender: it started to decline after 1989 among males but was steadily increasing over the study period among women. A decreasing trend for female breast cancer mortality began in 1994. Prostate cancer mortality trend is the only one showing two significant joinpoints: mortality decreased up to 1990, then it increased up to 1998 and, finally, was decreasing.Overall cancer mortality was decreasing in both sexes in Umbria and this favourable trend will probably continue and further improve since population screening against breast, cervix, and large bowel cancers were recently introduced. Besides gastric cancer, tobacco-related cancers and prostate cancer mainly contributed to mortality reduction in males, whereas breast cancer mainly contributed to declining mortality in females.The analysis of mortality trends is an important tool to monitor cancer control, and evaluate the outcomes of modifications in population lifestyle, environmental risks, and the effectiveness of health care [1]. Mortality reduction remains the main objective of interventions based on screening and treatment, and the ultimate indicator to assess the effectiveness of mos
%U http://www.biomedcentral.com/1471-2407/7/10